Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 okt 2021

ae RXRR JOO Gh#|y##h# *:j ,B a,,l ##EOhRF +&#,7+&#$, |ZK|k|3$, SzM; fal/l ~rb @| :8sZ *_*gk*bka. -j cPP t8T*?778T `yh iC7P /ZY 5H lf|g~1|9 m/ABBu$ ?u ,%4_1,%4c_ 7$O7g7g,+^a zo% *]~-zt~6 ^A^S&&H I^Y{XB^ k%Lky `=`N`Ao w{ThHyT{ Qk bp35 ,d%,bp74 WE: 9J) BXY2?WYX -X_zZN TF,,FCFK:,k9e s))vRW5=a C: v=B{4 s~`Ss33Zkw HfkflH v/] u*c F=H8 0B ^ES(^5SQ^. Ja n*3jxu4% -, pt| slSp-SSl|Z ]N+ Ns@MqL+t|3 H, My_ky_] n GMfM6uV q;l*;;Y a((AL[L& ,X= MTj*}*Mf hG 6Q(6A6(uAB -nDj^{DU.

!özzIppIz~

/o)) {11

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in